Across TCGA pan-cancer cohorts, CSNK1A1P1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CSNK1A1P1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CSNK1A1P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CSNK1A1P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

STAD, UCEC, and COAD are the cancer types where CSNK1A1P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.184	0.730	.001	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
COAD	DFS	Median	All	0.160	0.693	.020	6	view →
SKCM	DFS	Median	All	0.877	0.198	.028	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: CSNK1A1P1 tumor-vs-normal RNA expression · all CSNK1A1P1 data types